NCT06968923 Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device
| NCT ID | NCT06968923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universita di Verona |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2018-04-26 |
| Primary Completion | 2025-04-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2018-04-26 with a primary completion date of 2025-04-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To verify the non-inferiority, in terms of post-treatment (T1) clinical effectiveness, of a "multidomain" telerehabilitation (TR) protocol compared to conventional outpatient rehabilitation in patients with stroke sequelae, with respect to motor, cognitive, and language functions. The absence of statistically significant differences between the two groups regarding treatment effects for each targeted domain will be considered an indicator of non-inferiority.
Eligibility Criteria
Inclusion Criteria: * Age over 18 years. * First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 . * Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and/or cognitive deficits identified through the Oxford Cognitive Screen (OCS). * Availability of an ADSL or higher-speed internet connection at the patient's residence. * Ability of the patient and/or caregiver to understand and utilize the telerehabilitation system. * Provision of written informed consent. Exclusion Criteria: * Contemporanea partecipazione ad altri studi clinici; * Decadimento cognitivo * Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti; * Contratture fisse ai 4 arti valutate come 4/4 alla scala di Ashworth modificata (MAS) * Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06968923 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06968923 currently recruiting?
Yes, NCT06968923 is actively recruiting participants. Contact the research team at valentina.varalta@univr.it for enrollment information.
Where is the NCT06968923 trial being conducted?
This trial is being conducted at Verona, Italy.
Who is sponsoring the NCT06968923 clinical trial?
NCT06968923 is sponsored by Universita di Verona. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.